drugset / Trial / NCT00223977
2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a phase 3 clinical investigation. Patients who meet the eligibility criteria and provide signed informed consent will be randomized to receive one of two levels of Ferrlecit or oral iron in a 1:1:1 ratio.
Timeline
- Start
- 2003-12
- Primary completion
- 2004-11
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferrous Sulfate | Diagnostic / imaging agent | 325 mg | Oral |
| Subject | Sodium Ferric Gluconate Complex | Unknown | 125 mg | — |
| Subject | Sodium Ferric Gluconate Complex | Unknown | 250 mg | — |